Resumo

GOMEZ ORDONEZ, Silvia; GUTIERREZ ALVAREZ, Ángela María  e  VALENZUELA PLATA, Etna L.. Corticoids: 60 Years Later a Pending Subject. Rev. Cienc. Salud [online]. 2007, vol.5, n.3, pp.58-69. ISSN 1692-7273.

The objective of this article is to make a brief compilation of the physiology of the hypothalamic-pituitary-adrenal axis in order to understand the role of the exogenous corticoids as therapeutic tools in innumerable pathologies, but when used inappropriately, it can produce important deleterious effects. The history of the corticoids began 164 years ago in 1843 when Thomas Addison described the symptoms of the adrenal gland insufficiency. On September 21st 1948, almost one hundred years after, Dr. Hench injected cortisone for the first time in a patient with arthritis. In 1950 Hench, Kendall and Reichstein received the Nobel Prize in Medicine and Physiology. In the cortex of the adrenal glands, three different hormones are synthesized from cholesterol, and these hormones produce diverse effects on the homeostasis of the body. The synthetic glucocorticoids are classified by their anti-inflammatory power, half life, and mineralocorticoid effect; they operate in almost every cell through genomic and non genomic mechanisms of action producing different responses. This is the reason of their wide therapeutic effect in respiratory diseases like asthma and COPD, multiple sclerosis, rejection of transplants, among others.

Palavras-chave : Cortisol; hormone; Adisson disease; mineralocorticoids; adrenal glands.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )